Skip header and navigation

Refine By

45907 records – page 1 of 4591.

1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis.

https://arctichealth.org/en/permalink/ahliterature186649
Source
J Toxicol Environ Health B Crit Rev. 2003 Jan-Feb;6(1):55-83
Publication Type
Article
Author
K. Hughes
M E Meek
M. Walker
R. Beauchamp
Author Affiliation
Existing Substances Division, Environmental Health Directorate, Health Canada, Environmental Health Centre, Tunney's Pasture PL0802B1, Ottawa, Ontario, Canada K1A 0L2.
Source
J Toxicol Environ Health B Crit Rev. 2003 Jan-Feb;6(1):55-83
Language
English
Publication Type
Article
Keywords
Animals
Butadienes - metabolism - toxicity
Canada - epidemiology
Carcinogens, Environmental - toxicity
Environmental Exposure
Hazardous Substances - toxicity
Humans
Mutagens - toxicity
Neoplasms - chemically induced - epidemiology
Occupational Diseases - chemically induced - epidemiology
Risk assessment
Abstract
1,3-Butadiene has been assessed as a Priority Substance under the Canadian Environmental Protection Act. The general population in Canada is exposed to 1,3-butadiene primarily through ambient air. Inhaled 1,3-butadiene is carcinogenic in both mice and rats, inducing tumors at multiple sites at all concentrations tested in all identified studies. In addition, 1,3-butadiene is genotoxic in both somatic and germ cells of rodents. It also induces adverse effects in the reproductive organs of female mice at relatively low concentrations. The greater sensitivity in mice than in rats to induction of these effects by 1,3-butadiene is likely related to species differences in metabolism to active epoxide metabolites. Exposure to 1,3-butadiene in the occupational environment has been associated with the induction of leukemia; there is also some limited evidence that 1,3-butadiene is genotoxic in exposed workers. Therefore, in view of the weight of evidence of available epidemiological and toxicological data, 1,3-butadiene is considered highly likely to be carcinogenic, and likely to be genotoxic, in humans. Estimates of the potency of butadiene to induce cancer have been derived on the basis of both epidemiological investigation and bioassays in mice and rats. Potencies to induce ovarian effects have been estimated on the basis of studies in mice. Uncertainties have been delineated, and, while there are clear species differences in metabolism, estimates of potency to induce effects are considered justifiably conservative in view of the likely variability in metabolism across the population related to genetic polymorphism for enzymes for the critical metabolic pathway.
PubMed ID
12587254 View in PubMed
Less detail

The -1C to T polymorphism in the annexin A5 gene is not associated with the risk of acute myocardial infarction or sudden cardiac death in middle-aged Finnish males.

https://arctichealth.org/en/permalink/ahliterature53135
Source
Scand J Clin Lab Invest. 2005;65(2):133-40
Publication Type
Article
Date
2005
Author
K S Kaikkonen
S. Kakko
M L Kortelainen
J M Tapanainen
M J Savolainen
Y. Antero Kesäniemi
H V Huikuri
E R Savolainen
Author Affiliation
Division of Cardiology, Department of Internal Medicine, University of Oulu, Finland.
Source
Scand J Clin Lab Invest. 2005;65(2):133-40
Date
2005
Language
English
Publication Type
Article
Keywords
5' Untranslated Regions - genetics
Adult
Aged
Annexin A5 - genetics
Death, Sudden, Cardiac - epidemiology - etiology
Finland - epidemiology
Genetic markers
Genetic Predisposition to Disease
Genetic Screening
Humans
Male
Middle Aged
Myocardial Infarction - epidemiology - genetics
Polymorphism, Genetic
Research Support, Non-U.S. Gov't
Risk factors
Abstract
OBJECTIVE: A common polymorphism (-1C to T) in the translation initiation sequence of annexin A5 (ANV) gene has recently been associated with a decreased risk of acute myocardial infarction (AMI). The aim of the present study was to analyze the association between the ANV genepolymorphism and the risk of AMI and ischemic sudden cardiac death (SCD) in middle-aged Finnish males. MATERIAL AND METHODS: A case-control study involving three distinct groups of subjects was carried out: (1) victims of SCD (n=98), (2) survivors of AMI (n=212), and (3) randomly selected control subjects without any history of coronary heart disease (n=243). The ANV polymorphism was genotyped in each study group. RESULTS: Among the control group of healthy Finnish males the prevalence rates of the CC, CT, and TT genotypes were 83.1%, 15.2%, and 1.6%, respectively. Among the survivors of AMI, the prevalence rates of CC, CT, and TT were 79.7%, 20.3%, and 0%, respectively, and among the victims of SCD 83.7%, 16.3%, and 0%, respectively. No significant differences in the genotype or allele distributions were observed between the study groups. CONCLUSION: The -1C to T polymorphism in the ANV gene is not associated with the risk of AMI or SCD in middle-aged Finnish males.
PubMed ID
16025836 View in PubMed
Less detail

The 1% of the population accountable for 63% of all violent crime convictions.

https://arctichealth.org/en/permalink/ahliterature259131
Source
Soc Psychiatry Psychiatr Epidemiol. 2014 Apr;49(4):559-71
Publication Type
Article
Date
Apr-2014
Author
Falk, O
Wallinius, M
Lundström, S
Frisell, T
Anckarsäter, H
Kerekes, N
Source
Soc Psychiatry Psychiatr Epidemiol. 2014 Apr;49(4):559-71
Date
Apr-2014
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Aggression - psychology
Criminals - psychology - statistics & numerical data
Female
Humans
Male
Mental Disorders - epidemiology - psychology
Middle Aged
Registries
Risk factors
Substance-Related Disorders - epidemiology
Sweden
Violence - psychology - statistics & numerical data
Abstract
Population-based studies on violent crime and background factors may provide an understanding of the relationships between susceptibility factors and crime. We aimed to determine the distribution of violent crime convictions in the Swedish population 1973-2004 and to identify criminal, academic, parental, and psychiatric risk factors for persistence in violent crime.
The nationwide multi-generation register was used with many other linked nationwide registers to select participants. All individuals born in 1958-1980 (2,393,765 individuals) were included. Persistent violent offenders (those with a lifetime history of three or more violent crime convictions) were compared with individuals having one or two such convictions, and to matched non-offenders. Independent variables were gender, age of first conviction for a violent crime, nonviolent crime convictions, and diagnoses for major mental disorders, personality disorders, and substance use disorders.
A total of 93,642 individuals (3.9%) had at least one violent conviction. The distribution of convictions was highly skewed; 24,342 persistent violent offenders (1.0% of the total population) accounted for 63.2% of all convictions. Persistence in violence was associated with male sex (OR 2.5), personality disorder (OR 2.3), violent crime conviction before age 19 (OR 2.0), drug-related offenses (OR 1.9), nonviolent criminality (OR 1.9), substance use disorder (OR 1.9), and major mental disorder (OR 1.3).
The majority of violent crimes are perpetrated by a small number of persistent violent offenders, typically males, characterized by early onset of violent criminality, substance abuse, personality disorders, and nonviolent criminality.
Notes
Cites: JAMA Psychiatry. 2013 May;70(5):465-7123467760
Cites: Behav Genet. 2012 Jan;42(1):3-1821761238
Cites: Arch Gen Psychiatry. 2000 Oct;57(10):979-8611015816
Cites: Dev Psychopathol. 2001 Spring;13(2):355-7511393651
Cites: J Consult Clin Psychol. 1989 Dec;57(6):710-82600241
Cites: Arch Gen Psychiatry. 1992 Jun;49(6):476-831599373
Cites: Lancet. 1997 May 24;349(9064):1498-5049167458
Cites: Am J Psychiatry. 1997 Jun;154(6):840-59167513
Cites: Psychol Bull. 1998 Mar;123(2):123-429522681
Cites: Arch Gen Psychiatry. 1998 May;55(5):393-4019596041
Cites: Psychiatry Clin Neurosci. 2005 Feb;59(1):25-915679536
Cites: Sex Abuse. 2005 Jul;17(3):269-9216121839
Cites: Eur J Public Health. 2006 Jun;16(3):260-6616446293
Cites: Am J Psychiatry. 2006 Aug;163(8):1397-40316877653
Cites: Am J Epidemiol. 2006 Dec 15;164(12):1199-20817032695
Cites: Soc Psychiatry Psychiatr Epidemiol. 2007 Jun;42(6):477-8417450452
Cites: J Clin Psychiatry. 2008 Jan;69(1):12-2218312033
Cites: J Abnorm Psychol. 2008 May;117(2):396-40518489215
Cites: Int J Law Psychiatry. 2008 Aug-Sep;31(4):374-8318678408
Cites: BMC Psychiatry. 2008;8:9219032787
Cites: J Clin Psychiatry. 2009 Mar;70(3):362-919284931
Cites: PLoS Med. 2009 Aug;6(8):e100012019668362
Cites: Nord J Psychiatry. 2009;63(4):292-30019229735
Cites: Schizophr Bull. 2010 Jul;36(4):702-1218990713
Cites: Arch Sex Behav. 2010 Oct;39(5):1161-919888644
Cites: Psychol Med. 2011 Jan;41(1):97-10520334717
Cites: Arch Gen Psychiatry. 2010 Dec;67(12):1325-621135334
Cites: Clin Psychol Rev. 2011 Jul;31(5):872-8221550331
Cites: PLoS One. 2011;6(10):e2576822022445
Cites: Arch Gen Psychiatry. 2000 May;57(5):494-50010807490
PubMed ID
24173408 View in PubMed
Less detail

ß2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals.

https://arctichealth.org/en/permalink/ahliterature125626
Source
J Clin Endocrinol Metab. 2012 Jun;97(6):E1074-9
Publication Type
Article
Date
Jun-2012
Author
Mette Thomsen
Morten Dahl
Anne Tybjærg-Hansen
Børge G Nordestgaard
Author Affiliation
Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
Source
J Clin Endocrinol Metab. 2012 Jun;97(6):E1074-9
Date
Jun-2012
Language
English
Publication Type
Article
Keywords
Adult
Body mass index
Cohort Studies
Denmark - epidemiology
Diabetes Mellitus - epidemiology - genetics
Female
Genetic Predisposition to Disease - epidemiology - genetics
Genotype
Humans
Male
Membrane Proteins - genetics
Obesity - epidemiology - genetics
Polymorphism, Single Nucleotide - genetics
Proteins - genetics
Receptor, Melanocortin, Type 4 - genetics
Receptors, Adrenergic, beta-2 - genetics
Risk factors
Abstract
The ß(2)-adrenergic receptor (ADRB2) influences regulation of energy balance by stimulating catecholamine-induced lipolysis in adipose tissue. The rare functional ADRB2rs1800888(Thr164Ile) polymorphism could therefore influence risk of obesity and subsequently diabetes.
We tested the hypothesis that the ADRB2rs1800888(Thr164Ile) polymorphism associates with risk of obesity and diabetes and compared effect sizes with those of FTO(rs9939609), MC4R(rs17782313), and TMEM18(rs6548238).
We conducted a population-based cohort study in Copenhagen, Denmark.
We genotyped more than 64,000 individuals from the Danish general population.
We evaluated body mass index (BMI), obesity (BMI =30 kg/m(2)), and diabetes.
Rare allele frequencies were 0.02 for T for ADRB2rs1800888(Thr164Ile), 0.40 for A for FTOrs9939609, 0.25 for C for MC4Rrs17782313, and 0.20 for T for TMEM18rs6548238. For rare vs. common homozygotes, odds ratio for obesity was 3.32 (95% confidence interval = 1.08-10.19) for ADRB2rs1800888(Thr164Ile), 1.42 (1.35-1.52) for FTOrs9939609, 1.18 (1.06-1.30) for MC4Rrs17782313, and 1.28 (1.10-1.50) for TMEM18rs6548238 (common vs. rare). Corresponding odds ratios for diabetes were 1.85 (0.24-14.29), 1.22 (1.07-1.39), 0.96 (0.80-1.16), and 1.61 (1.17-2.22), respectively. After adjustment for BMI, only TMEM18rs6548238 remained associated with diabetes. BMI was increased in rare vs. common homozygotes in FTOrs9939609, MC4Rrs17782313, and TMEM18rs6548238 (common vs. rare) but not in ADRB2rs1800888(Thr164Ile).
Our results suggest that ADRB2rs1800888(Thr164Ile) rare vs. common homozygotes are not significantly associated with an increase in BMI measured continuously but may be associated with an increased risk of obesity. Also, TMEM18rs6548238 associated with risk of diabetes after adjustment for BMI. These findings need confirmation in other studies.
PubMed ID
22466342 View in PubMed
Less detail

[2 epidemics of whirlpool dermatitis in Sweden--the risks are increasing].

https://arctichealth.org/en/permalink/ahliterature238949
Source
Lakartidningen. 1985 Apr 10;82(15):1376
Publication Type
Article
Date
Apr-10-1985

2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus.

https://arctichealth.org/en/permalink/ahliterature121853
Source
Cardiovasc Diabetol. 2012;11:93
Publication Type
Article
Date
2012
Author
Loghman Henareh
Stefan Agewall
Author Affiliation
Department of Cardiology Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden. loghman.henareh@karolinska.se
Source
Cardiovasc Diabetol. 2012;11:93
Date
2012
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aged, 80 and over
Angina, Unstable - blood - epidemiology - mortality
Biological Markers - blood
Blood Glucose - metabolism
Chi-Square Distribution
Female
Glucose Tolerance Test
Humans
Incidence
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction - blood - epidemiology - mortality
Predictive value of tests
Prognosis
Proportional Hazards Models
Prospective Studies
Recurrence
Risk assessment
Risk factors
Smoking - adverse effects - epidemiology
Stroke - blood - epidemiology - mortality
Sweden - epidemiology
Time Factors
Abstract
The incidence of cardiovascular events remains high in patients with myocardial infarction (MI) despite advances in current therapies. New and better methods for identifying patients at high risk of recurrent cardiovascular (CV) events are needed. This study aimed to analyze the predictive value of an oral glucose tolerance test (OGTT) in patients with acute myocardial infarction without known diabetes mellitus (DM).
The prospective cohort study consisted of 123 men and women aged between 31-80 years who had suffered a previous MI 3-12 months before the examinations. The exclusion criteria were known diabetes mellitus. Patients were followed up over 6.03???1.36 years for CV death, recurrent MI, stroke and unstable angina pectoris. A standard OGTT was performed at baseline.
2-h plasma glucose (HR, 1.27, 95% CI, 1.00 to 1.62; P?
Notes
Cites: N Engl J Med. 2000 Jan 20;342(3):145-5310639539
Cites: Cardiovasc Diabetol. 2012;11:2122397368
Cites: Am J Med. 2000 Nov;109(7):538-4211063954
Cites: J Clin Invest. 2001 Aug;108(4):635-611518739
Cites: Diabetologia. 2001 Sep;44 Suppl 2:S54-6411587051
Cites: Circulation. 2001 Nov 27;104(22):2673-811723017
Cites: Diabetes Care. 2001 Dec;24(12):2043-811723080
Cites: BMJ. 2002 Jan 12;324(7329):71-8611786451
Cites: Dtsch Med Wochenschr. 2002 May 3;127(18):953-711987015
Cites: Eur Heart J. 2002 Aug;23(16):1267-7512175663
Cites: Diabetes Care. 2002 Oct;25(10):1845-5012351489
Cites: Int J Cardiol. 2004 Oct;97(1):21-415336801
Cites: Eur Heart J. 1985 Mar;6(3):199-2262863148
Cites: J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-672698218
Cites: Am J Hypertens. 1994 Jul;7(7 Pt 1):615-227946163
Cites: Lancet. 1994 Nov 19;344(8934):1383-97968073
Cites: BMJ. 1995 Mar 4;310(6979):555-97888928
Cites: Diabetes Care. 1996 Mar;19(3):257-678742574
Cites: Diabetologia. 1996 Dec;39(12):1577-838960845
Cites: Diabetes Care. 1998 Sep;21(9):1529-339727904
Cites: Circ Res. 1999 Mar 19;84(5):489-9710082470
Cites: Diabetes Care. 1999 Jun;22(6):920-410372242
Cites: J Am Coll Cardiol. 1999 Jul;34(1):146-5410400004
Cites: Lancet. 1999 Aug 21;354(9179):617-2110466661
Cites: Eur Heart J. 2004 Nov;25(22):1990-715541834
Cites: Am J Cardiol. 2005 Aug 1;96(3):363-516054458
Cites: Diabet Med. 2005 Sep;22(9):1212-716108851
Cites: Clin Ther. 2005;27 Suppl B:S42-5616519037
Cites: Clin Physiol Funct Imaging. 2007 Jan;27(1):60-617204040
Cites: Circ J. 2007 Jun;71(6):834-4117526977
Cites: Circulation. 2007 Jul 10;116(2):151-717576864
Cites: Circulation. 2007 Nov 27;116(22):2634-5317951284
Cites: Heart Vessels. 2009 Mar;24(2):90-519337791
Cites: Prim Care Diabetes. 2009 Nov;3(4):205-919875348
Cites: Diabetes Care. 2010 Jan;33 Suppl 1:S62-920042775
Cites: Cardiovasc Diabetol. 2010;9:7521070650
Cites: Cardiovasc Diabetol. 2011;10:5621702911
Cites: Hypertension. 2000 Aug;36(2):245-910948085
PubMed ID
22873202 View in PubMed
Less detail

2nd-generation HIV surveillance and injecting drug use: uncovering the epidemiological ice-berg.

https://arctichealth.org/en/permalink/ahliterature84543
Source
Int J Public Health. 2007;52(3):166-72
Publication Type
Article
Date
2007
Author
Reintjes Ralf
Wiessing Lucas
Author Affiliation
Department of Public Health, Faculty Life Sciences, Hamburg University of Applied Sciences, Hamburg, Germany. Ralf.Reintjes@rzbd.haw-hamburg.de
Source
Int J Public Health. 2007;52(3):166-72
Date
2007
Language
English
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - epidemiology - prevention & control - therapy
Cost-Benefit Analysis
Europe - epidemiology
HIV Infections - epidemiology - prevention & control - therapy
Hepatitis C - epidemiology
Humans
Norway - epidemiology
Population Surveillance
Prevalence
Risk factors
Risk-Taking
Substance Abuse, Intravenous - epidemiology
Turkey - epidemiology
Abstract
OBJECTIVES: HIV/AIDS surveillance methods are under revision as the diversity of HIV epidemics is becoming more apparent. The so called "2nd generation surveillance (SGS) systems" aim to enhance surveillance by broadening the range of indicators to prevalence, behaviors and correlates, for a better understanding and a more complete and timely awareness of evolving epidemics. METHODS: Concepts of HIV SGS are reviewed with a special focus on injecting drug users, a major at-risk and hard to reach group in Europe, a region with mainly low or concentrated epidemics. RESULTS: The scope of HIV/AIDS surveillance needs to be broadened following principles of SGS. Specifically for IDUs we propose including hepatitis C data as indicator for injecting risk in routine systems like those monitoring sexually transmitted infections and information on knowledge and attitudes as potential major determinants of risk behavior. CONCLUSIONS: The suggested approach should lead to more complete and timely information for public health interventions, however there is a clear need for comparative validation studies to assess the validity, reliability and cost-effectiveness of traditional and enhanced HIV/AIDS surveillance systems.
PubMed ID
17958283 View in PubMed
Less detail

2-year clinical performance of a fluoride-containing fissure sealant in young schoolchildren at caries risk.

https://arctichealth.org/en/permalink/ahliterature34233
Source
Am J Dent. 1997 Jun;10(3):115-9
Publication Type
Article
Date
Jun-1997
Author
A. Carlsson
M. Petersson
S. Twetman
Author Affiliation
Public Dental Clinic, Vallås, Sweden.
Source
Am J Dent. 1997 Jun;10(3):115-9
Date
Jun-1997
Language
English
Publication Type
Article
Keywords
Analysis of Variance
Cariostatic Agents - analysis - therapeutic use
Chi-Square Distribution
Child
Colony Count, Microbial
Composite Resins - chemistry - therapeutic use
Dental Caries - epidemiology - prevention & control
Dental Plaque - microbiology
Fluorides - analysis - pharmacology - therapeutic use
Humans
Lactobacillus - drug effects - isolation & purification
Pit and Fissure Sealants - therapeutic use
Prevalence
Risk assessment
Saliva - chemistry - microbiology
Statistics, nonparametric
Streptococcus mutans - drug effects - isolation & purification
Sweden - epidemiology
Abstract
PURPOSE: To evaluate the clinical performance of Helioseal-F, a fluoride-containing fissure sealant, in school children at caries risk. MATERIALS AND METHODS: A caries risk assessment based on past caries experience, saliva microbial tests, buffer capacity and frequency of sugar intake was carried out in 204 healthy children, 6-7 years of age. Children exhibiting one or more risk factors were considered at caries risk (n = 121) and their permanent molars were sealed with a fluoride-containing fissure sealant, thus forming a fissure sealant group (FSG). The remaining 83 children with low caries risk received no fissure sealants and constituted a reference group (RG). Both groups were followed for 2 years. From 15 children of both groups, unstimulated whole saliva was collected 1 month after sealant placement in order to determine fluoride levels. In another 20 children, a split-mouth study design was utilized to compare the colonization of mutans streptococci adjacent to and on F-containing sealants and conventional controls. The sealants were placed by dental hygienists according to the manufacturers' instructions. RESULTS: A total of 431 fissure sealants were placed at baseline. Complete retention was found in 76.6% during the study period while 22.0% were partially lost. Six sealants (1.4%) were completely lost. The enamel caries incidence was 45% lower (P
PubMed ID
9545884 View in PubMed
Less detail

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

https://arctichealth.org/en/permalink/ahliterature264224
Source
Lancet. 2015 Jun 6;385(9984):2255-63
Publication Type
Article
Date
Jun-6-2015
Author
Tiia Ngandu
Jenni Lehtisalo
Alina Solomon
Esko Levälahti
Satu Ahtiluoto
Riitta Antikainen
Lars Bäckman
Tuomo Hänninen
Antti Jula
Tiina Laatikainen
Jaana Lindström
Francesca Mangialasche
Teemu Paajanen
Satu Pajala
Markku Peltonen
Rainer Rauramaa
Anna Stigsdotter-Neely
Timo Strandberg
Jaakko Tuomilehto
Hilkka Soininen
Miia Kivipelto
Source
Lancet. 2015 Jun 6;385(9984):2255-63
Date
Jun-6-2015
Language
English
Publication Type
Article
Keywords
Aged
Cognition Disorders - epidemiology - prevention & control
Diet
Double-Blind Method
Exercise
Exercise Therapy
Humans
Male
Middle Aged
Neuropsychological Tests
Risk assessment
Vascular Diseases - epidemiology - prevention & control
Abstract
Modifiable vascular and lifestyle-related risk factors have been associated with dementia risk in observational studies. In the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), a proof-of-concept randomised controlled trial, we aimed to assess a multidomain approach to prevent cognitive decline in at-risk elderly people from the general population.
In a double-blind randomised controlled trial we enrolled individuals aged 60-77 years recruited from previous national surveys. Inclusion criteria were CAIDE (Cardiovascular Risk Factors, Aging and Dementia) Dementia Risk Score of at least 6 points and cognition at mean level or slightly lower than expected for age. We randomly assigned participants in a 1:1 ratio to a 2 year multidomain intervention (diet, exercise, cognitive training, vascular risk monitoring), or a control group (general health advice). Computer-generated allocation was done in blocks of four (two individuals randomly allocated to each group) at each site. Group allocation was not actively disclosed to participants and outcome assessors were masked to group allocation. The primary outcome was change in cognition as measured through comprehensive neuropsychological test battery (NTB) Z score. Analysis was by modified intention to treat (all participants with at least one post-baseline observation). This trial is registered at ClinicalTrials.gov, number NCT01041989.
Between Sept 7, 2009, and Nov 24, 2011, we screened 2654 individuals and randomly assigned 1260 to the intervention group (n=631) or control group (n=629). 591 (94%) participants in the intervention group and 599 (95%) in the control group had at least one post-baseline assessment and were included in the modified intention-to-treat analysis. Estimated mean change in NTB total Z score at 2 years was 0·20 (SE 0·02, SD 0·51) in the intervention group and 0·16 (0·01, 0·51) in the control group. Between-group difference in the change of NTB total score per year was 0·022 (95% CI 0·002-0·042, p=0·030). 153 (12%) individuals dropped out overall. Adverse events occurred in 46 (7%) participants in the intervention group compared with six (1%) participants in the control group; the most common adverse event was musculoskeletal pain (32 [5%] individuals for intervention vs no individuals for control).
Findings from this large, long-term, randomised controlled trial suggest that a multidomain intervention could improve or maintain cognitive functioning in at-risk elderly people from the general population.
Academy of Finland, La Carita Foundation, Alzheimer Association, Alzheimer's Research and Prevention Foundation, Juho Vainio Foundation, Novo Nordisk Foundation, Finnish Social Insurance Institution, Ministry of Education and Culture, Salama bint Hamdan Al Nahyan Foundation, Axa Research Fund, EVO funding for University Hospitals of Kuopio, Oulu, and Turku and for Seinäjoki Central Hospital and Oulu City Hospital, Swedish Research Council, Swedish Research Council for Health, Working Life and Welfare, and af Jochnick Foundation.
Notes
Comment In: Nat Rev Neurol. 2015 May;11(5):24825799934
PubMed ID
25771249 View in PubMed
Less detail

A 2-year self-help smoking cessation manual intervention among middle-aged Finnish men: an application of the transtheoretical model.

https://arctichealth.org/en/permalink/ahliterature217852
Source
Prev Med. 1994 Jul;23(4):507-14
Publication Type
Article
Date
Jul-1994
Author
U E Pallonen
L. Leskinen
J O Prochaska
C J Willey
R. Kääriäinen
J T Salonen
Author Affiliation
Cancer Prevention Research Center, University of Rhode Island, Kingston 02881.
Source
Prev Med. 1994 Jul;23(4):507-14
Date
Jul-1994
Language
English
Publication Type
Article
Keywords
Adult
Analysis of Variance
Chi-Square Distribution
Confounding Factors (Epidemiology)
Finland
Humans
Longitudinal Studies
Male
Manuals as Topic
Middle Aged
Risk factors
Self Care
Smoking Cessation
Abstract
A 2-year self-help manual smoking cessation intervention was conducted among a panel of middle-aged Finnish men (n = 265) who were recruited proactively in a longitudinal cardiovascular risk factor surveillance study.
Intervention utilized the stages of change concept of the transtheoretical model. The stages were assessed in the treatment condition at baseline of the cessation study and after that by mail every sixth month. Assessments were followed by an immediate mailing of a stage-based self-help manual matching the stage of change at that time. A usual care group was assessed annually but received no treatment.
A significant time x intervention effect (P
PubMed ID
7971879 View in PubMed
Less detail

45907 records – page 1 of 4591.